Urothelial Carcinoma Clinical Trials Database - Free Access to 113 Studies
Access comprehensive clinical trial information for Urothelial Carcinoma through Pure Global AI's free database. This collection includes 113 clinical trials across multiple phases including Phase 2, N/A, Phase 1. Currently, 37 trials are actively recruiting participants.
Research for Urothelial Carcinoma is being conducted in United States of America, China, Taiwan and 7+ other countries. Leading sponsors include National Taiwan University Hospital and University of Michigan Rogel Cancer Center. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
A Study of BL-B01D1 + PD-1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Observational Study of Muscle Invasive Urothelial Carcinoma Participants Treated With Adjuvant Nivolumab in France
JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study
Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial Cancer
Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma
Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer
18F-LN1 PET/CT in Urothelial Carcinomas
Adjuvant Radiotherapy and Combined Adjuvant Treatment Strategy for UTUC
Liquid Biospy for Urinary Cancers
Immunotherapy in Upper Tract Urothelial Carcinoma
A Study of BL-B01D1+SI-B003 in the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors
Disitamab Vedotin Combined With Radiotherapy for Bladder Preservation
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
HER2 and LA/mUC: A Multi-country Chart Review Cohort Study
Naptumomab Estafenatox in Combination With Pembrolizumab Preceded by Obinutuzumab in Patients With Urothelial Cancers
Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria
A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract
Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer
A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
Pure Global AI provides free access to 113 clinical trials studying Urothelial Carcinoma, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include National Taiwan University Hospital, University of Michigan Rogel Cancer Center, Seagen Inc., among others.